Widespread immunity from prior SARS-CoV-2 infections and vaccination has kept global circulation of the virus at low levels through mid-2026, with WHO reporting test positivity below 5% and moderate overall public health risk as of late July. CDC surveillance shows declining hospitalizations and seasonal patterns resembling influenza rather than pandemic spread, with no novel coronavirus strain meeting criteria for widespread severe disease or international emergency. This supports the market's 96.2% implied probability against a new pandemic. Realistic shifts could occur if a highly immune-evasive variant emerges with elevated virulence or if zoonotic spillover of a distinct coronavirus produces sustained high transmission and mortality exceeding endemic baselines, though current model consensus and monitoring data indicate low likelihood before year-end.